The global Ibuprofen market is valued at over USD 1 billion and is expected to grow steadily.
The Ibuprofen market is expected to grow at a CAGR of around 4–5% during the forecast period.
BASF SE and IOL Chemicals and Pharmaceuticals Limited are the largest Ibuprofen API supplier.
Asia-Pacific dominates 27 percent of the global production of Ibuprofen.
The Ibuprofen market faces challenges such as regulatory compliance, supply chain disruptions, intense competition, quality and safety concerns, and environmental regulations.